-
1Academic Journal
Συγγραφείς: L. V. Adamyan, E. A. Bogdanova, E. V. Sibirskaya, T. M. Glybina, M. B. Garunova, Л. В. Адамян, Е. А. Богданова, Е. В. Сибирская, Т. М. Глыбина, М. Б. Гарунова
Πηγή: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 59, № 2 (2014); 43-47 ; Российский вестник перинатологии и педиатрии; Том 59, № 2 (2014); 43-47 ; 2500-2228 ; 1027-4065 ; undefined
Θεματικοί όροι: адренокортикотропный гормон, congenital adrenal hyperplasia, reproductive health, 11'-hydroxyprogesterone, adrenocorticotropic hormone, врожденная гиперплазия коры надпочечников, репродуктивное здоровье, 17-гидроксипрогестерон
Περιγραφή αρχείου: application/pdf
Relation: https://www.ped-perinatology.ru/jour/article/view/203/243; BongiovanniA.M., RootA.W. The adrenogenital syndrome. N Engl J Med 1963; 268: 1283-1399.; Gallais A. Le syndrome genitosurrenal, etude anatomo-clinique. Paris 1912; 224.; Верещинский А. О. Надпочечно-половой синдром с точки зрения хирургической патологии и терапии. Вестн хир 1923; 4: 3: 207—219. (Vereshchynsky A.O. Adrenal-sexual syndrome in terms of surgical pathology and therapy. Vestn khir 1923; 4: 3: 207-219.); Therrell B. Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 1:15—30.; Pang S., Murphey W., Levine L.S. et al. A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab 1982; 3: 413-420.; Pang S., Wallace M. Hofman L. et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988; 6: 866—874.; Speiser P., Dupont В., Rubinstein P. et al. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985; 4: 650—667.; Fitness J., Dixit N., Webster D. et al. Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1999; 3: 960—966.; Cam J., Moshang T. Jr., Bongiovanni A.M. et al. Elevated 17-hydroxyprogesterone and testosterone in a newborn with; beta-hydroxysteroid dehydrogenase deficiency. N Engl J Med 1985; 10: 618-621.; Speiser P., Dupont J., Zhu D. et al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 1992; 2: 584—595.; Wtchel S., Lee P. /dentification of heterozygotic carriers of 21-hydroxylase deficiency: sensitivity of ACTH stimulation tests. Am J Med Genet 1982; 4: 337—342.; Clayton P., Miller W., Oberfield S.E. et al. Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res 2002; 4: 188—195.; White P., Speiser P. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 3: 245—291.; Pang S., Spence D.A., New M.I. Newborn screening for congenital adrenal hyperplasia with special reference to screening in Alaska. AnnNYAcad Sci 1985; 458: 90—102.; Pang S.Y., Wallace M.A., Hofman L. et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988; 81:6:866—874.; Карева М.А., Орлова Е.М. Адреногенитальный синдром: прошлое, настоящее и будущее. Пробл эндокринол 2011; 1: 66—70. (Kareva M.A., Orlova E.M. Adrenogenital syndrome: past, present and future. Probljendokrinol 2011; 1: 66-70.); Forest M., Morel Y, David M. et al. Prenatal treatment of congenital adrenal hyperplasia. Trends Endocrinol Metab 1998; 7: 284-289.; New M., Carlson A., Obeid J. et al. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 2001; 12: 5651-5657.; Morel Y, Miller L. Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet 1991; 20: 1—68.; Partsch C, Sippell W, MacKenzie I.Z. et al. The steroid hormonal milieu of the undisturbed human fetus and mother at 16-20 weeks gestation. J Clin Endocrinol Metab 1991; 5: 969—974.; Kay H, Bird I., Coe C.L. et al. Antenatal steroid treatment and adverse fetal effects: what is the evidence? J Soc Gynecol Investig 2000; 5: 269-278.; AlizaiN., Thomas D., LilfordRJ. et al. Feminizing genitoplasty for congenital adrenal hyperplasia: what happens at puberty? JUrol 1999; 5: 1588-1591.; Elhalaby E., Abo Sikeena M. Delayed presentation of congenital diaphragmatic hernia. Pediatr Surg Int 2002; 5-6: 480-485.; Mullis P., Hindmarsh P., Brook C.G. et al. Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency. Eur J Pediatr 1990; 1: 22—25.; Charmandari E., Lichtarowicz-Krynska E., Hindmarsh PC. etal. Congenital adrenal hyperplasia: management during critical illness. Arch Dis Child 2001; 1: 26—28.; Escobar-Morreale H., Sanchon R., San Millan J.L. et al. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 2008; 2: 527-533.; Richards G., Grumbach M., Kaplan S.L. et al. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia. J Clin Endocrinol Metab 1978; 6: 1208—1215.; Lonning, P., Jacobs S., Jones A.L. et al. The influence of CGS 16949A on peripheral aromatisation in breast cancer patients. Br J Cancer 1991; 5: 789-793.; Speiser P., Azziz R-, Baskin L.S. et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 9: 4133-4160.; Hughes I., Read G. Menarche and subsequent ovarian function in girls with congenital adrenal hyperplasia. Horm Res 1982; 2: 100-106.; Bachelot A., Chakhtoura Z., Samara-Boustani D. et al. Bone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency. Int J Pediatr Endocrinol 2010.; RosenfieldR., BickelS., Razdan A.K. et al. Amenorrhea related to progestin excess in congenital adrenal hyperplasia. Obstet Gynecol 1980; 2: 208-215.; StikkelbroeckN., HermusA., Suliman H.M. et al. Asymptomatic testicular adrenal rest tumours in dolescent and adult males with congenital adrenal hyperplasia: basal and follow-up investigation after 2.6 years. J Pediatr Endocrinol Metab 2004; 4: 645-653.; Riad-Fahmy D., Read G., Walker R.F. et al. Steroids in saliva for assessing endocrine function. Endocr Rev 1982; 4: 367—395.; Kemp Т., Safaeian M., Miner S. et al. Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels. Front Oncol 2012; 2: 61.; Groschl M., Rauh M., Dorr H.G. et al. Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2002; 3: 1200-1204.; Vuorento T., Huhtaniemi I. Daily levels of salivary progesterone during menstrual cycle in adolescent girls. Fertil Steril 1992; 4: 685-690.; Gray S., Ebe L., Feldman H.A. et al. Salivary progesterone levels before menarche: a prospective study of adolescent girls. J Clin Endocrinol Metab 2010; 7: 3507-3511.; Auchus J. Management of the adult with congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010; 614107.; Klingensmith G., Garcia S., Jones H. et al. Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility. J Pediatr 1977; 6: 996-1004.; Richards G., Grumbach M., Kaplan S.L. et al. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia. J Clin Endocrinol Metab 1978; 6: 1208-1215.; Lin-Su K., Harbison M., Lekarev O. et al. Final adult height in children with congenital adrenal hyperplasia treated with growth hormone. J Clin Endocrinol Metab 2011; 6: 1710-1717.; Korth-Schutz, S., Virdis R., Saenger P. et al. Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab 1978; 3:452—458.; Kang M., Kim S., Lee Y.A. et al. Relationships of basal level of serum 17-hydroxyprogesterone with that of serum androstenedione and their stimulated responses to a low dose of ACTH in young adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Korean Med Sci2011; 11: 1454-1460.; Rosenfield R., Ehrlich E., Cleary R.F. et al. Adrenal and ovarian contributions to the elevated free plasma androgen levels in hirsute women. J Clin Endocrinol Metab 1972; 1: 92-98.; RosenfieldR., Fang V., Dupon С et al. The effects of low doses of depot estradiol and testosterone in teenagers with ovarian failure and Turner's syndrome. J Clin Endocrinol Metab 1973; 4: 574—580.; MaffeiL., Murata Y, Rochira V. etal. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 2004; 1: 61—70.; Rappaport R., Cornu G., Rover P. et al. Statural growth in congenital adrenal hyperplasia treated with hydrocortisone. J Pediatr 1968; 5: 760-766.; Helleday J., Siwers В., Ritzen E.M. et al. Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency. J Clin Endocrinol Metab 1993; 4: 933—936.; Holmes-Walker D., Conway G., Honour J.W. et al. Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol 1995; 3: 291—296.; Abd El Dayem S., Anwar G., Salama H et al. Bone mineral density, bone turnover markers, lean mass, and fat mass in Egyptian children with congenital adrenal hyperplasia. Arch Med Sci 2010; 1: 104-110.; undefined
Διαθεσιμότητα: https://www.ped-perinatology.ru/jour/article/view/203
-
2Academic Journal
Πηγή: Ukrainian Journal of Pediatric Endocrinology; № 1 (2016); 83—86
Украинский журнал детской эндокринологии; № 1 (2016); 83—86
Український журнал дитячої ендокринології; № 1 (2016); 83—86Θεματικοί όροι: врожденная дисфункция коры надпочечников, кортизол, 17-гидроксипрогестерон, гиперандрогения, глюкокортикоиды, диагностика, congenital adrenal hyperplasia, cortisol, 17-hydroxyprogesterone, hyperandrogenism, glucocorticoids, diagnostics, вроджена дисфункція кори наднирників, 17-гідроксипрогестерон, гіперандрогенія, глюкокортикоїди, діагностика, 3. Good health
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: http://ujpe.com.ua/article/view/79743
-
3Academic Journal
Συγγραφείς: ИОНОВА Т.А., КАЛИНЧЕНКО Н.Ю., ТЮЛЬПАКОВ А.Н., НИЖНИК А.Н.
Περιγραφή αρχείου: text/html
-
4Academic Journal
Πηγή: Проблемы эндокринологии.
Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, ВРОЖДЕННАЯ ДИСФУНКЦИЯ КОРЫ НАДПОЧЕЧНИКОВ (ВДКН),CONGENITAL ADRENAL CORTICAL HYPERPLASIA (CAH),17-ГИДРОКСИПРОГЕСТЕРОН (17-ОHП),17-HYDROXYPROGESTERONE (17-OHP),ТАНДЕМНАЯ ХРОМАТО-МАСС-СПЕКТРОМЕТРИЯ (LC-MS/MS),LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (LC-MS/MS),SCREENING.,СКРИНИНГ
Περιγραφή αρχείου: text/html
